Combination Treatment of Balloon Pulmonary Angioplasty and Direct Oral Anticoagulant in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated by Protein S Deficiency
Abstract
:1. Introduction
2. Case Presentation
2.1. Past History
2.2. Before Referral
2.3. On Admission
2.4. Balloon Pulmonary Angioplasty
2.5. Following Procedure
3. Discussion
3.1. Therapeutic Strategy for CTEPH and Protein S Deficiency
3.2. Angioplasty to Improve Exercise Tolerance
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Simonneau, G.; Torbicki, A.; Dorfmüller, P.; Kim, N. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur. Respir. Rev. 2017, 26, 160112. [Google Scholar] [CrossRef] [PubMed]
- Humbert, M.; Kovacs, G.; Hoeper, M.M.; Badagliacca, R.; Berger, R.M.F.; Brida, M.; Carlsen, J.; Coats, A.J.S.; Escribano-Subias, P.; Ferrari, P.; et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J. 2022, 43, 3618–3731. [Google Scholar] [CrossRef] [PubMed]
- Ten Kate, M.K.; van der Meer, J. Protein S deficiency: A clinical perspective. Haemophilia 2008, 14, 1222–1228. [Google Scholar] [CrossRef] [PubMed]
- Lian, T.Y.; Liu, J.Z.; Guo, F.; Zhou, Y.P.; Wu, T.; Wang, H.; Li, J.Y.; Yan, X.X.; Peng, F.H.; Sun, K.; et al. Prevalence, Genetic Background, and Clinical Phenotype of Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension. JACC Asia 2022, 2, 247–255. [Google Scholar] [CrossRef] [PubMed]
- Ando, M.; Takamoto, S.; Okita, Y.; Matsukawa, R.; Nakanishi, N.; Kyotani, S.; Satoh, T. Operation for chronic pulmonary thromboembolism accompanied by thrombophilia in 8 patients. Ann. Thorac. Surg. 1998, 66, 1919–1924. [Google Scholar] [CrossRef]
- Akbayrak, H.; Tekumit, H. Pulmonary thromboendarterectomy in a combined thrombophilia patient. Cardiovasc. J. Afr. 2019, 30, e4–e6. [Google Scholar] [CrossRef]
- Lindner, J.; Jansa, P.; Salaj, P.; Kunstýr, J.; Grus, T.; Maruna, P.; Bláha, J.; Rubes, D.; Ambroz, D.; Mlejnsý, F.; et al. Thrombophilia and pulmonary endarterectomy. Prague Med. Rep. 2009, 110, 51–59. [Google Scholar] [PubMed]
- Puebla-Aldama, D.; Cueto-Robledo, G.; Barragan-Martinez, M.D.; Roldan-Valadez, E.; Navarro-Vergara, D.I.; Garcia-Cesar, M.; Heredia-Flores, K.L.; Torres-Rojas, M.B.; Garcia-Treminio, C.F.; Cueto-Romero, H.D. Review of Functional Status and Hemodynamic Parameters in Patients Diagnosed with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) with and without Antiphospholipid Syndrome (APLS). Curr. Probl. Cardiol. 2022, in press. [Google Scholar] [CrossRef] [PubMed]
- Dahlbäck, B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 2008, 112, 19–27. [Google Scholar] [CrossRef] [PubMed]
- Skelley, J.W.; White, C.W.; Thomason, A.R. The use of direct oral anticoagulants in inherited thrombophilia. J. Thromb. Thrombolysis. 2017, 43, 24–30. [Google Scholar] [CrossRef]
- Aoki, T.; Sugimura, K.; Tatebe, S.; Miura, M.; Yamamoto, S.; Yaoita, N.; Suzuki, H.; Sato, H.; Kozu, K.; Konno, R.; et al. Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: Long-term effects and procedure-related complications. Eur. Heart J. 2017, 38, 3152–3159. [Google Scholar] [CrossRef] [PubMed]
- Shinkura, Y.; Nakayama, K.; Yanaka, K.; Kinutani, H.; Tamada, N.; Tsuboi, Y.; Satomi-Kobayashi, S.; Otake, H.; Shinke, T.; Emoto, N.; et al. Extensive revascularisation by balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension beyond haemodynamic normalisation. EuroIntervention 2018, 13, 2060–2068. [Google Scholar] [CrossRef] [PubMed]
- Inami, T.; Kataoka, M.; Kikuchi, H.; Goda, A.; Satoh, T. Balloon pulmonary angioplasty for symptomatic chronic thromboembolic disease without pulmonary hypertension at rest. Int. J. Cardiol. 2019, 289, 116–118. [Google Scholar] [CrossRef] [PubMed]
- Aoki, T.; Sugimura, K.; Terui, Y.; Tatebe, S.; Fukui, S.; Miura, M.; Yamamoto, S.; Yaoita, N.; Suzuki, H.; Sato, H.; et al. Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty—A randomized controlled study. Int. J. Cardiol. Heart Vasc. 2020, 29, 100579. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Izumida, T.; Imamura, T.; Ushijima, R.; Kinugawa, K. Combination Treatment of Balloon Pulmonary Angioplasty and Direct Oral Anticoagulant in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated by Protein S Deficiency. Medicina 2023, 59, 909. https://doi.org/10.3390/medicina59050909
Izumida T, Imamura T, Ushijima R, Kinugawa K. Combination Treatment of Balloon Pulmonary Angioplasty and Direct Oral Anticoagulant in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated by Protein S Deficiency. Medicina. 2023; 59(5):909. https://doi.org/10.3390/medicina59050909
Chicago/Turabian StyleIzumida, Toshihide, Teruhiko Imamura, Ryuichi Ushijima, and Koichiro Kinugawa. 2023. "Combination Treatment of Balloon Pulmonary Angioplasty and Direct Oral Anticoagulant in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated by Protein S Deficiency" Medicina 59, no. 5: 909. https://doi.org/10.3390/medicina59050909